Early Phase 1 Malignant Solid Tumor Clinical Trials
4 recruitingEarly Phase 1
What is a Early Phase 1 trial?
Early Phase 1 trials are the earliest stage of testing in humans. These small studies focus on how a drug is processed in the body and how it affects the body, often enrolling just a handful of participants to establish initial safety data.
Showing 1–4 of 4 trials
Recruiting
Early Phase 1
A Clinical Study on Evaluating Intravenous Administration of IDOV-SAFE
Advanced Malignant Solid Tumor of Digestive System
Peking University89 enrolled1 locationNCT06380309
Recruiting
Early Phase 1
Study on the Safety and Efficacy of Intravenous Administration of IDOV-SAFETM in the Treatment of Advanced Solid Tumors
Advanced Malignant Solid Tumor
Fudan University38 enrolled1 locationNCT06718946
Recruiting
Early Phase 1
Assessment of the Safety and Tolerability of ex Vivo Next-generation Neoantigen-selected Tumor-infiltrating Lymphocyte (TIL) Therapy in Advanced Epithelial Tumors and Immune Checkpoint Blockade (ICB) Resistant Solid Tumors
Epithelial Tumors, MalignantMalignant Solid Tumor
Vall d'Hebron Institute of Oncology10 enrolled1 locationNCT05141474
Recruiting
Early Phase 1
Evaluate the Safety and Tolerability of JCXH-212 Monotherapy and Combined With Toripalimab in the Treatment of Malignant Solid Tumors
Malignant Solid Tumors
Peking University Cancer Hospital & Institute24 enrolled1 locationNCT05579275